NCT00418938 SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial Status COMPLETED Phase PHASE2
NCT00415636 Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer Status COMPLETED Phase PHASE1
NCT00414934 18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer. Status UNKNOWN Phase N/A
NCT00413283 Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00411450 Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment Status COMPLETED Phase PHASE2
NCT00400504 Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®) Status UNKNOWN Phase N/A
NCT00397774 Physical Activity and Functioning in Palliative Cancer Patients - a Clinical Randomised Trial Status COMPLETED Phase PHASE3
NCT00396864 Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma Status COMPLETED Phase PHASE1
NCT00388557 Effect of Ketoconazole on the Pharmacokinetics of Vinflunine Status COMPLETED Phase PHASE1
NCT00387153 Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer Status TERMINATED Phase PHASE1
NCT00386152 A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy Status TERMINATED Phase PHASE2
NCT00385866 Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries Status COMPLETED Phase NA
NCT00381095 A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer Status TERMINATED Phase PHASE4
NCT00380406 PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial Status COMPLETED Phase PHASE3